- Risk Factors
- 7 Types
- Support Groups
Thyroid cancer facts*
- The thyroid gland produces thyroid hormones which are important in the normal regulation of the metabolism of the body.
- Thyroid cancer is three times more common in women than in men.
- There are four major types of thyroid cancer: papillary, follicular, medullary (MTC), and anaplastic.
- The cause of thyroid cancer is unknown, but certain risk factors have been identified and include a family history of goiter, exposure to high levels of radiation, and certain hereditary syndromes.
- The National Cancer Institute recommends that anyone who received radiation to the head or neck in childhood be examined by a doctor every one to two years to detect potential thyroid cancer.
- The most common signs and symptoms of thyroid cancer include a lump, or thyroid nodule, that can be felt in the neck, trouble swallowing, throat or neck pain, swollen lymph nodes in the neck, cough, and vocal changes.
- If a lump in the thyroid is found, the only certain way to tell whether it is cancerous is by needle or surgery biopsy and examining the thyroid tissue obtained.
- A CEA blood test, physical exam, X-rays, CT scans, PET scans, ultrasounds, and MRIs may also be used to help establish a definitive diagnosis and determine staging.
- Surgery is the most common form of treatment for thyroid cancer that has not spread to other areas of the body. Radiation therapy, chemotherapy, and radioactive iodine treatment are also medical treatment options in addition to surgery.
- The survival rate and prognosis of thyroid cancer depends upon a few factors, including the individual's age, the size of the tumor, and whether there is metastasis or spread of the tumor.
- It is not possible to prevent most cases of thyroid cancer.
- Thyroid cancer is the third most common solid cancer tumor in children and the most common endocrine malignancy.
What is the thyroid?
The thyroid gland is a butterfly-shaped gland located in the front of the neck and is most well-known and responsible for producing thyroid hormone, the chemical in the body that is responsible for regulating the body's metabolism. It has two lobes, right and left, that are connected by a fibrous bridge called the isthmus.
Parafollicular cells in the thyroid produce the thyroid hormone. Too much thyroid production can cause hyperthyroidism (hyper=too much) where a person can experience rapid heartbeat and palpitations, sweating, heat intolerance, weight loss, and anxiety. Hypothyroidism (hypo=too little) may cause lethargy, weight gain, hair thinning, gravelly voice, and cold intolerance. The pituitary gland in the brain controls the amount of thyroid hormone that is produced by secreting thyroid stimulating hormone (TSH).
What is thyroid cancer?
Thyroid cancer affects more than 20,000 people in the U.S. every year but accounts for only 1% of new cancers that are diagnosed. Thyroid cancer is the most common endocrine cancer.
DNA (mutations) that occur spontaneously or in response to an environmental exposure or a toxic substance can alter normal thyroid cells. The genetic changes cause the cells to multiply very rapidly without the normal controls found in the rest of the gland. Any of the cell types found in the thyroid gland can mutate into a specific type of cancer.
Cancer is different than goiter, an enlargement of the thyroid gland that may be associated with hyper or hypothyroidism. Worldwide, the most common cause of goiter is iodine deficiency. In countries where table salt is iodinated, the autoimmune disease Hashimoto's thyroiditis, is the most common cause. Graves' disease, another autoimmune disease, can also be associated with thyroid enlargement.
Research from the U.S. National Cancer Institute (NCI) has found that while the number of thyroid cancers being diagnosed has increased in the past 30 years, the death rate from thyroid cancer has remained the same. This suggests that there are not more cancers occurring but instead health care professionals and patients have become better at finding lumps in the thyroid gland and making the diagnosis.
What causes thyroid cancer?
The exact cause of thyroid cancer is not known, though there are factors that may be associated with an increased risk of developing the cancer. Even if the risk factors are present, there is not a way of knowing whether cancer might develop; patients without risk factors still may develop thyroid cancer.
What are the risk factors for thyroid cancer?
Women are three times more likely to develop thyroid cancer than men and at a slightly younger age (40 to 50 years old for women versus 60 to 70 for men).
A rapidly growing nodule is more likely to be cancerous and is an ominous sign.
X-rays and CT scans of the neck use low doses of radiation but medical testing has not been found to cause thyroid cancer. Nevertheless, in general, it is important to limit the amount of exposures to the least amount of radiation that will provide a clear enough image to help make a diagnosis.
Diets low in iodine may increase the risk of thyroid cancer, but in developed countries, there is usually enough iodine used as food additives so that this is not a problem. Lower levels of iodine in the diet may enhance the risk of radiation induced thyroid cancer.
There may be a relationship between poorly controlled diabetes and an increased risk of thyroid cancer.
Children who have had radiation exposure to the neck are at higher risk for thyroid cancer. Studies have looked at children who were given radiation treatments 50-60 years ago when the risks of radiation where less well understood, and their rate of thyroid cancer is increased. Children and women survivors of nuclear reactor accidents (Chernobyl in 1986 has been studied) have an increased risk of thyroid and other types of cancer.
Agent orange exposure may increase the risk of developing thyroid cancer.
There may be a genetic predisposition to thyroid cancer, especially in certain rare types of thyroid cancer.
What are the symptoms and signs of thyroid cancer?
Most often, a thyroid cancer is found when the patient or the patient's health care professional feels (palpates) a lump or nodule in the lower front of the neck where the thyroid is located. It is most often painless and found incidentally, by chance. Occasionally, an enlarged lymph node may be palpated by itself in the more lateral neck or in addition to a thyroid nodule.
Most patients have normal thyroid function at the time the nodule is discovered and have no symptoms related to hyper or hypothyroidism.
If the tumor grows large enough, it can affect nearby structures. There may be difficulty swallowing food (dysphagia) if the tumor compresses the esophagus, but this is rare. If the recurrent laryngeal nerve, which controls the vocal cords, is involved, hoarseness may develop due to vocal cord paralysis.
In children, lumps in the neck are found frequently. Most often they are not in the thyroid gland itself. Aside from swollen lymph nodes associated with infections like pharyngitis, strep throat, or an ear infection (otitis media), lumps should not be ignored. In pediatric patients, thyroid cancer is the third most common solid tumor malignancy and the most common endocrine malignancy. The first sign might be a lump that is felt in the thyroid gland.
What are thyroid nodules?
A thyroid nodule is an abnormal growth found within the thyroid gland. It may be solid, fluid filled (cystic) -- usually with a jelly like substance called colloid -- or a combination of both.
Most often nodules are found incidentally when the patient or health care professional feels the neck. Whether the nodule is benign or cancerous cannot necessarily be determined just by feeling it and further tests may be warranted.
What are the different types of thyroid cancer?
Thyroid malignancies are classified based upon which cell type is involved.
Well differentiated cancers (in which thyroid cells are less abnormal looking) include:
- Papillary thyroid carcinoma: This is the most common type of thyroid cancer. Papillary thyroid cancer accounts for 80% of cases.
- Hürthle cell carcinoma: This is a rare variant of papillary cancer (also known as oncocytic carcinoma).
- Follicular thyroid carcinoma: Follicular cancer is the second most common type of thyroid cancer. The follicular variety accounts for 10% of cases.
- Medullary thyroid carcinoma: This thyroid cancer type arises from the C cells in the thyroid that produce calcitonin. Medullary thyroid cancers (MTC) comprise 5% of all cases.
- Anaplastic thyroid cancer: This rare cancer involves thyroid cells are very abnormal looking, accounting for 1% of all cases.
- Lymphoma: This rare cancer is most often non-Hodgkin's B cell type.
- Sarcoma: This type of thyroid cancer is very rare.
How do health care professionals diagnose thyroid cancer?
The diagnosis of thyroid cancer often occurs before symptoms develop, when a lump is discovered in the thyroid gland. This may occur on routine physical exam of the neck by a health care provider, or it may be found by the patient.
Once a lump in the thyroid is discovered, it is important to know whether it is benign or malignant (cancerous).
An ultrasound usually is performed to assess whether there is a single nodule or whether multiple nodules are present. Ultrasound can determine whether the nodule is fluid filled or solid. Ultrasound also can determine the general appearance of thyroid looking for inflammation or irregularities and the presence of nearby enlarged lymph nodes that may represent metastatic cancer.
Fine needle aspiration biopsy (FNAB) is usually the next step. It is a procedure performed to obtain a sample of cells from the nodule to determine if it is cancerous. Using ultrasound, a thin needle is placed into the nodule and cells from the nodule are obtained. These cells can be examined under a microscope by a pathologist to determine whether a cancer is present and if so, what type of cancer it is.
Sometimes, the results of the aspiration are unclear or indeterminate, and the aspiration may need to be repeated to get a better sample and more cells to study.
Guidelines developed by the American Thyroid Association help the provider interpret the results of the ultrasound and fine needle aspiration biopsy. When evaluated together, the test results give direction as to whether the nodule is benign or malignant (cancerous), and help inform the choice of treatment options.
Radio-iodine testing may be considered if the results of the FNAB don't provide a definite answer as to whether a nodule is benign or malignant. The patient swallows some radioactive iodine which is taken up by the thyroid gland. The gland is scanned by a Geiger counter-type apparatus that determines how much radioactive iodine has been taken up by the thyroid gland and any thyroid nodules. If the nodule picks up much of the iodine, it is referred to as a "hot nodule." Hot nodules are rarely cancerous. Nodules that take up little to no iodine are referred to as "cold nodules." Although the overwhelming majority of cold nodules are benign, 5% turn out to be malignant.
Although thyroid scans may be helpful, it is not a first-line test and fine needle aspiration of the gland is a much more useful test. There is an exception. In the patient with a thyroid nodule whose TSH (thyroid stimulating hormone) level is low, the next step may be a radio-iodine test. The risk for cancer in a patient who is hyperthyroid (low TSH) and who has a "hot nodule" is very low and biopsy may not be required.
Blood tests may be ordered to determine the function of the thyroid gland. Measuring blood levels of thyroid-stimulating hormone (TSH) secreted by the pituitary gland turns out to be very effective in determining thyroid function, including whether the patient is hyperthyroid or hypothyroid.
Calcitonin levels may be increased in medullary thyroid cancer (MTC), but because MTC is very rare, this test is not recommended to screen for cancer.
MTC, FMTC, and MEN are hereditary cancers. Genetic testing may be done in family members of people with these types of cancers. As well, other blood tests may be ordered, including CEA, RET proto-oncogene, calcium, and calcitonin. Screening for other associated diseases might include tests looking for a tumor known as pheochromocytoma.
What are treatment options for thyroid cancer?
Thyroid cancer treatment usually requires surgery to remove the tumor. Two options are available, and decisions as to which option to pursue depend upon the clinical situation. Guidelines from the American Thyroid Association and the National Comprehensive Cancer Network can help the surgeon and patient decide on the best type of surgery for the situation.
- Lobectomy: The thyroid has two lobes joined in the middle with a fibrous tissue bridge called the isthmus. If the tumor is confined to only a small area, the surgeon may just remove the affected lobe.
- Total thyroidectomy: This is the most common surgery for thyroid cancer and the goal is to completely remove the thyroid gland and hopefully ensure that the cancer will not recur.
- Lymph node resection: Thyroid cancer can spread to local lymph nodes, and these nodes often are removed. Affected lymph nodes may only be recognized at the time of surgery.
- Open biopsy: Sometimes, the cancerous nature of a thyroid nodule is unclear, even after fine needle aspiration. A surgeon may operate to remove the nodule and send all the tissue for evaluation by a pathologist to make the diagnosis of cancer.
If the thyroid gland has been removed, the body will no longer be able to make thyroid hormone, and daily thyroid hormone replacement will be necessary. Routine thyroid hormone blood tests will need to be performed to ensure there is an adequate amount of thyroid hormone to allow the body to function properly. Thyroid hormone replacement will be lifelong in total thyroidectomy patients.
Radioactive iodine (radioiodine, I-131)
Iodine is routinely absorbed by thyroid tissue. Radioiodine may be administered after surgery to destroy any remnant thyroid tissue remaining after thyroidectomy. The decision to use this treatment depends upon the type and extent of the thyroid cancer and the levels of thyroid stimulating hormone (TSH) produced by the pituitary gland.
In certain thyroid cancers, where the tumor does not take up iodine, radiation therapy may be considered in place of radioactive iodine. Radioactive iodine update tests performed before surgery can assess whether or not iodine is taken up by the thyroid gland.
Chemotherapy is not commonly used for most thyroid cancers but may be used in certain clinical situations when the thyroid cancer does not respond to other treatments.
What kind of support is available for those with thyroid cancer?
Patients, families, and friends are all affected by a diagnosis of cancer is made. Support is available not only for the patient but for all those who are close to the patient. Hospitals, clinics, and health care professionals' offices often have specially trained staff to help patients and families address their physical, emotional, and spiritual needs.
It is important for the patient and family to understand the disease, the treatment options, the expected outcomes, and the journey that will occur with cancer. Family members will benefit from being present for provider visits during the diagnosis and treatment, as well as with follow-up appointments. This allows all to be involved in advocating for the patient, since there is so much information to understand and absorb; it can be overwhelming.
There are many community resources available as well. The American Cancer Society is a good place to begin. They have local offices and may be contacted online.
What is the prognosis for patients with thyroid cancer? What is the survival rate for patients with thyroid cancer?
There are many types of thyroid cancer, and outcome depends upon the type of thyroid cancer, its stage, and the type of thyroid cancer treatment received.
Patients who have papillary or follicular cancer that is confined to the thyroid gland may expect a normal life expectancy with treatment. Prognosis may be better for women who are younger than 40 years of age.
Patients with anaplastic cancer do poorly, with many surviving only a few months after diagnosis. The five-year survival rate for this cancer is less than 10%.
What is the likelihood of thyroid cancer recurrence?
The recurrence rate of thyroid cancer depends upon whether the cancer remains localized within the thyroid gland or whether it has spread or metastasized to local structures in the neck or to distant sites in the body.
In general, the recurrence risk of a cancer that has not spread is very low. For example, Italian researchers found that among patients with papillary cancer of the thyroid gland, those with a low risk of disease had a recurrence rate of about 1.4% at eight years.
Researchers from the Mayo Clinic followed patients for up to 15 years and concluded that low risk patients had a recurrence rate of 3%-5%. However, they noted that more recently, thyroid cancer was being diagnosed much earlier and with the appropriate surgery, cure was much more likely and survival rate after surgery was very high.
Is it possible to prevent thyroid cancer?
There is little one can do to prevent thyroid cancer aside from avoiding excessive exposure to radiation.
What is the latest research on thyroid cancer?
Research continues regarding the best treatment for the different types of thyroid cancers. New drugs are being developed that specifically target the thyroid cancer cells by attacking specific genes or proteins.
MTC (medullary thyroid cancer) research and treatments include developing anti-cancer antibodies and attaching them to radioactive iodine to be injected into the body so that the combination molecule is taken up by the thyroid gland and then specifically attaches to and destroys cancer cells.
Clinical trials continue to enroll patients with many diseases, including thyroid cancer. If appropriate, your health care professional may be a resource in finding a clinical trial that may be beneficial. Clinical trials that are enrolling patients can be found at the U.S. National Cancer Institute web site (https://www.cancer.gov/about-cancer/treatment/clinical-trials/search).
Health Solutions From Our Sponsors
Dal Maso, L., A. Tavilla, F. Pacini, et al. "Survival of 86,690 patients with thyroid cancer: A population-based study in 29 European countries from EUROCARE-5." Eur J Cancer 77 Apr. 2017: 140-52.
Durante, C. et al. "Papillary thyroid cancer: time course of recurrences during postsurgery surveillance." J Clin Endocrinol Metab 98 (2013): 636-642.
Grant, C.S. "Recurrence of papillary thyroid cancer after optimized surgery." Gland Surg 4.1 February 2015: 52-62.
Haugen, B.R., E.K. Alexander, K.C. Bible, et al. "2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer." Thyroid 1 Jan. 2016: 1-133.
Le, K.T., M.P. Sawicki, M.B. Wang, et al. "High Prevalence of Agent Orange Exposure Among Thyroid Cancer patients in the National VA Health care System." Endocr Pract 22.6 Jan. 2016: 899-902.
Lentsch, E. J., et al. "Thyroid Cancer Staging." Medscape. Sept. 6, 2013.
Ruel, E., S. Thomas, M. Dinan, et al. "Adjuvant radioactive iodine therapy is associated with improved survival for patients with intermediate risk papillary thyroid cancer." J Clin Endocrinol Metab 100.4 Feb. 2015: 1529-1536.